Use of long-acting cabotegravir + rilpivirine during hemodialysis and solid organ transplantation

AIDS. 2023 Jul 15;37(9):1491-1493. doi: 10.1097/QAD.0000000000003567.

Authors

Leonardo F Rezzonico^{1

2}, Luca Baldassari^{1

3}, Francesco Peracchi^{1

3}, Marco Merli¹, Massimo Puoti^{1

3}, Roberto Rossotti¹

Affiliations

¹ Department of Infectious Disease, ASST Grande Ospedale Metropolitano Niguarda, Milan.
² School of Medicine, University of Pavia, Pavia.
³ School of Medicine, University of Milano-Bicocca, Milan, Italy.

PMID: 37395256
DOI: 10.1097/QAD.0000000000003567

No abstract available

Publication types

Letter

MeSH terms

Anti-HIV Agents* / therapeutic use
Anti-Retroviral Agents / therapeutic use
HIV Infections* / drug therapy
Humans
Organ Transplantation*
Pyridones / therapeutic use
Renal Dialysis
Rilpivirine / therapeutic use

Substances

cabotegravir
Anti-Retroviral Agents
Pyridones
Rilpivirine
Anti-HIV Agents